EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium



Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium



British Journal of Pharmacology 97(3): 983-989



1. The effects of various vasoactive peptides and the involvement of the endothelium in these effects were studied on small human skeletal muscle arteries (SMA) and pig splenic arteries (SA) in vitro. 2. Under control conditions, neuropeptide Y (NPY) caused potent and strong contractions of both arteries. The maximal effect of NPY 500 nM was similar to that of phenylephrine and noradrenaline (10 microns). Endothelin was approximately 10 fold more potent than NPY in contracting SA, and the maximal response to endothelin 50 nM was 130% of that evoked by phenylephrine. 3. After removal of the endothelium (by rubbing the inner surface of the arteries) neither the maximal effect nor the EC50 value of NPY on SMA and SA or those of endothelin on SA were changed from control conditions. 4. The substance P (SP)-induced relaxation of precontracted SMA and SA during control conditions (80-90%) was abolished or greatly reduced after endothelium removal. 5. Under control conditions, calcitonin gene-related peptide (CGRP) was about 10 times more potent than vasoactive intestinal polypeptide (VIP) in relaxing SMA. After endothelium removal the relaxation induced by CGRP on SMA and SA and that of VIP on SMA were not changed from control conditions. 6. It is concluded that, in the SMA and SA, the potent vasoconstrictor effects of NPY and endothelin are mediated by direct actions on the vascular smooth muscle and not via a release of an endothelium-derived contracting factor. Relaxation induced by SP but not that of CGRP and VIP seems to be mediated via the endothelium.

(PDF emailed within 0-6 h: $19.90)

Accession: 039164378

Download citation: RISBibTeXText

PMID: 2474355

DOI: 10.1111/j.1476-5381.1989.tb12040.x



Related references

Constrictor responses of the novel peptide human urotensin II and endothelin-1 compared in endothelium-denuded human arteries and veins in vitro. British Journal of Pharmacology 131(Proceedings Supplement): 30P, October, 2000

Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptides in the rat. British Journal of Pharmacology 104(2): 311-320, 1991

Time course of flow-induced vasodilation in skeletal muscle: contributions of dilator and constrictor mechanisms. American Journal of Physiology Heart and Circulatory Physiology 288(4): H1499-H1507, 2005

Time course of flow-induced vasodilation in skeletal muscle: contributions of dilator and constrictor mechanisms. American Journal of Physiology. Heart and Circulatory Physiology 288(4): H1499-H1507, 2004

Beta-adrenergic dilator interaction with the constrictor response in resistance vessels of skeletal muscle during hemorrhage. Acta Physiologica Scandinavica 108(1): 77-83, 1980

Absence of neurogenic constrictor or dilator responses of human small pial arteries. FASEB Journal 6(4): A1462, 1991

Beta adrenergic dilator interaction with the constrictor response in resistance vessels of skin and skeletal muscle during hemorrhage. Acta Physiologica Scandinavica: 9a, 1980

Potent constrictor actions of endothelin-1, endothelin-2, and endothelin-3 in rat isolated portal vein. Hypertension 19(2 Suppl): Ii79-Ii86, 1992

A novel capsaicin derivative VOA induced relaxation in rat mesenteric and aortic arteries: involvement of CGRP, NO, cGMP, and endothelium-dependent activities. Journal of Cardiovascular Pharmacology 42(4): 511-520, 2003

An assessment of the anabolic skeletal actions of the common-region peptides derived from the CGRP and calcitonin prohormones. Annals of the New York Academy of Sciences 657: 50-62, 1992

Endothelin is a potent constrictor of human intracranial arteries and veins. Blood Vessels 26(5): 249-253, 1989

Endothelin is a potent constrictor of isolated human resistance arteries. British Journal of Pharmacology 95(SUPPL): 722P, 1988

Endothelin is a potent constrictor of human coronary arteries in vitro. Journal of the American College of Cardiology 13(2 SUPPL A): 85A, 1989

The acetylcholine paradox: a constrictor of human small coronary arteries even in the presence of endothelium. Clinical and Experimental Pharmacology & Physiology 18(1): 33-36, 1991

Endothelium dependent modulation of the pressor actions of endothelin sarafotoxin peptides in the isolated rat superior mesenteric arterial bed. European Journal of Pharmacology 183(5): 1791-1792, 1990